Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Elena Guerini Rocco"'
Autor:
Zheqi Li, Yang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen, Kevin M. Levine, Nolan M. Priedigkeit, Azadeh Nasrazadani, Simak Ali, Laki Buluwela, Spencer Arnesen, Jason Gertz, Jennifer K. Richer, Benjamin Troness, Dorraya El-Ashry, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Massimo Cristofanilli, Maritza A. Montanez, Prithu Sundd, Callen T. Wallace, Simon C. Watkins, Caterina Fumagalli, Elena Guerini-Rocco, Li Zhu, George C. Tseng, Nikhil Wagle, Jason S. Carroll, Paul Jank, Carsten Denkert, Maria M. Karsten, Jens-Uwe Blohmer, Ben H. Park, Peter C. Lucas, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Publikováno v:
Cancer Res
Constitutively active estrogen receptor α (ER/ESR1) mutations have been identified in approximately one-third of ER+ metastatic breast cancers. Although these mutations are known as mediators of endocrine resistance, their potential role in promotin
Autor:
Konstantinos, Venetis, Francesco, Pepe, Elisabetta, Munzone, Elham, Sajjadi, Gianluca, Russo, Pasquale, Pisapia, Mariia, Ivanova, Giuseppina, Bonizzi, Davide, Vacirca, Alessandra, Rappa, Alberto, Ranghiero, Sergio Vincenzo, Taormina, Giuseppe, Viale, Giancarlo, Troncone, Massimo, Barberis, Elena, Guerini-Rocco, Umberto, Malapelle, Nicola, Fusco
Publikováno v:
Cells. 11(22)
Somatic mutations in
Autor:
Filippo de Marinis, Francesca Porta, Elena Guerini-Rocco, Carmine Valenza, Giuseppe Curigliano, Chiara Catania, Alessandra Rappa, Massimo Barberis, Giuseppe Viale
Publikováno v:
Current Oncology, Vol 28, Iss 292, Pp 3384-3392 (2021)
Current Oncology
Current Oncology
We present a case of a woman with epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma who received gefitinib for 2 years and obtained a partial response. The patient then developed liver metastasis and a breast lesion, displaying high
Autor:
Eleonora Pagan, Richard D. Gelber, Fabio Conforti, Christos Sotiriou, Silvana Pileggi, Anna Sapino, Caterina Marchiò, Philippe Aftimos, Rossella Graffeo, Chiara Pesenti, Laetitia Collet, Giulia Peruzzotti, Vincenzo Bagnardi, Giovanni Corso, Marco Colleoni, Tommaso De Pas, Giuseppe Viale, Laura Pala, Martine Piccart, Caterina Fumagalli, Elena Guerini Rocco, Emilia Montagna, Sergio Marchini, Aron Goldhirsch
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, 59
Breast, Vol 59, Iss, Pp 94-101 (2021)
Breast, 59
Breast, Vol 59, Iss, Pp 94-101 (2021)
Background We report here for the first time, a comprehensive characterization of biological and clinical features of early-stage triple negative Invasive Lobular Carcinomas(TN-ILCs) Methods We analyzed all consecutive patients with early-stage TN-IL
Autor:
Elham Sajjadi, Konstantinos Venetis, Marianna Noale, Hatem A. Azim, Concetta Blundo, Giuseppina Bonizzi, Eugenia Di Loreto, Giovanna Scarfone, Stefano Ferrero, Stefania Maggi, Massimo Barberis, Paolo Veronesi, Viviana E. Galimberti, Giuseppe Viale, Nicola Fusco, Fedro A. Peccatori, Elena Guerini-Rocco
Publikováno v:
Cells; Volume 11; Issue 15; Pages: 2286
Breast cancer during pregnancy (PrBC) is a rare tumor with only a little information on its immune landscape. Here, we sought to characterize the cellular composition of the tumor microenvironment (TME) of PrBC and identify its differences from early
Autor:
Vincenzo Di Lauro, Andrea Gombos, Ines Deleu, Matthew Barber, Bettina Müller, Roswitha Kammler, Jacquie Chirgwin, Caterina Fumagalli, Guy Jerusalem, Edda Simoncini, Katsumasa Kuroi, Meredith M. Regan, Christel Fontaine, Isabella Leone, Massimo Barberis, Marta Rita Reforgiato, Marco Colleoni, Stefan Aebi, Erika Hitre, Kathryn P. Gray, Paola Rafaniello Raviele, Joaquín Gavilá, Aron Goldhirsch, Angelo Di Leo, Per Karlsson, Elena Guerini-Rocco, Seamus O'Reilly, Elisabetta Munzone, Patrick Neven, Sibylle Loibl, Giuseppe Viale, Alastair M. Thompson, Marie-Pascale Graas
Publikováno v:
Clinical Cancer Research. 27:504-512
Purpose:Women with hormone receptor–positive early breast cancers have a persistent risk of relapse and biomarkers for late recurrence are needed. We sought to identify tumor genomic aberrations associated with increased late-recurrence risk.Experi
Autor:
Umberto Malapelle, Marco Invernizzi, Nicola Fusco, Caterina Fumagalli, Elena Guerini-Rocco, Roberto Piciotti, Konstantinos Venetis, Elham Sajjadi, Giulia Viale, Carmen Criscitiello
Immune Checkpoint Inhibitors (ICIs) have remarkably modified the way solid tumors are managed, including breast cancer. Unfortunately, only a relatively small number of breast cancer patients significantly respond to these treatments. To maximize the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfe1d81f8159afafe64fed549856425
http://hdl.handle.net/11588/881958
http://hdl.handle.net/11588/881958
Autor:
Elena Guerini-Rocco, Gerardo Botti, Maria Pia Foschini, Caterina Marchiò, Mauro Giuseppe Mastropasqua, Giuseppe Perrone, Elena Roz, Alfredo Santinelli, Isabella Sassi, Viviana Galimberti, Luca Gianni, Giuseppe Viale
Publikováno v:
Tumori. 108(3)
Pathologic evaluation of early breast cancer after neoadjuvant therapy is essential to provide prognostic information based on tumor response to treatment (pathologic complete response [pCR] or non-pCR) and to inform therapy decisions after surgery.
Autor:
Sara Gandini, Joana Pereira, Giovanni Corso, Antonia Girardi, Giacomo Montagna, Paolo Veronesi, Simone Pietro De Angelis, Joana Figueiredo, Bernardo Bonanni, Raquel Seruca, Elena Guerini Rocco, Gabriella Pravettoni, Patrícia Carneiro, Virgilio Sacchini, Federica Corso
Publikováno v:
Journal of Cellular and Molecular Medicine
E-cadherin protein (CDH1 gene) integrity is fundamental to the process of epithelial polarization and differentiation. Deregulation of the E-cadherin function plays a crucial role in breast cancer metastases, with worse prognosis and shorter overall
Autor:
Hannah Y Wen, Rodrigo Gularte-Mérida, Jorge S. Reis-Filho, Britta Weigelt, Elena Guerini-Rocco, Lorenzo Ferrando, Hong Zhang, Emad A. Rakha, Francisco Beca, Arnaud Da Cruz Paula, Simon S K Lee, Fresia Pareja, Pier Selenica
Publikováno v:
Histopathology
Aims Acinic cell carcinoma (ACC) of the breast is a rare histological form of triple-negative breast cancer (TNBC). Despite its unique histology, targeted sequencing analysis has failed to identify recurrent genetic alterations other than those found